Coiante Scott M 4
4 · AGILE THERAPEUTICS INC · Filed Jan 31, 2019
Insider Transaction Report
Form 4
Coiante Scott M
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2019-01-29+172,600→ 172,600 totalExercise: $0.84Exp: 2029-01-28→ Common Stock (172,600 underlying) - Award
Employee Stock Option (Right to Buy)
2019-01-29+38,500→ 38,500 totalExercise: $2.50Exp: 2029-01-28→ Common Stock (38,500 underlying)
Footnotes (1)
- [F1]This option was granted on January 29, 2019. 25% of the shares subject to the stock option vest on January 29, 2020, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on January 29, 2023.